Financial Data and Key Metrics Changes - In 2024, the company achieved 11% operational revenue growth and a 15% increase in adjusted net income operationally, indicating strong financial performance [22][23]. Business Line Data and Key Metrics Changes - The innovative companion animal portfolio grew 14% operationally, with all key franchises delivering double-digit growth [23]. - The livestock portfolio also grew 5% operationally, surpassing the historic industry average [26]. Market Data and Key Metrics Changes - The dermatology franchise has helped over 25 million dogs and is projected to reach a market size of $2.5 billion by 2028, showcasing significant market potential [24]. Company Strategy and Development Direction - The company continues to focus on an omnichannel strategy, enhancing customer access through clinics, retail, and home delivery [23]. - There is an emphasis on integrating advanced technologies like generative AI into R&D processes to accelerate discovery and optimize development timelines [25]. - The strategic divestiture of certain product portfolios aligns with the focus on high-growth opportunities [26]. Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strength of the portfolio and the ability to adapt to market changes, highlighting a long runway of opportunity ahead [27][28]. - The company remains committed to delivering meaningful outcomes for animals and their caretakers, reinforcing its purpose-driven approach [28]. Other Important Information - The company received conditional licensure for an avian flu vaccine for chickens, positioning it to support customers in addressing evolving threats [25]. Q&A Session Summary Question: How does the compensation committee use the compensation actually paid total compensation figures in its calculation of the CEO target total compensation award for the upcoming year? - The board considers competitive practices and performance, with 92% of the CEO's compensation based on performance incentives, both short-term and long-term [31][32].